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Background: Fasting during the month of Ramadan could lead to acute complications and 
increased hypoglycemic risk of patients with type 2 diabetes. Therefore, diabetes is one of the 
diseases that need careful observation and special considerations during Ramadan including 
patients’ education and counseling.
Objectives: To evaluate the impact of Ramadan focused education program on acute compli-
cations and biomedical parameters.
Methods: A prospective nonrandomized interventional controlled design was run on three 
phases: before, during, and after Ramadan on 262 type 2 diabetes patients. The intervention 
group (n=140) received focused individualized diabetic education sessions and antidiabetic 
medications adjustment before and after Ramadan, while the control group (n=122) received 
standard diabetic care. A validated hypoglycemia questionnaire was used in both groups 
to assess the change of the risk. Patients were advised to adjust the dosage and timing of 
antidiabetic agents according to the recommendations for management of diabetes during 
Ramadan. Primary outcomes were postintervention change of hypoglycemia score and 
HbA1c over 6-month follow-up. Data were presented as mean ± standard deviation. HbA1c 
was expressed in percentage.
Results: The hypoglycemic scores before, during, and after Ramadan were 14.21±8.50, 
6.36±6.17, and 5.44±5.55 in the intervention group, respectively (P,0.001) and 14.01±5.10, 
13.46±5.30, and 9.27±4.65 in the control group, respectively (P,0.001). HbA1c levels were 
9.79±1.89, 8.26±1.54, and 8.52±1.61 before, during, and after Ramadan in the intervention 
group, respectively (P,0.001), and 10.04±1.47, 9.54±1.38, and 9.59±1.79 in the control group, 
respectively (P,0.001). Post-Ramadan reductions of HbA1c and hypoglycemic scores were 
significantly higher in the intervention group (-13.0% vs -4.5%, P=0.004 for HbA1c and -61.7% 
vs -33.8%, P,0.001 for hypoglycemic score). Low-density lipoprotein cholesterol improved 
in the intervention group from 2.41±0.91 mmol/L before Ramadan to 2.28±0.68 mmol/L after 
Ramadan (P,0.001). No statistically significant effects were observed on blood pressure or 
body weight in the intervention group. Also, no change was observed in the control group.
Conclusion: Ramadan educational program had a positive impact with reduction of hypoglyce-
mic risk, HbA1c, and low-density lipoprotein cholesterol. Therefore, it could be recommended 
for patients with increased risk of hypoglycemia during Ramadan fasting.
Keywords: complications, diabetes, fasting, Saudi Arabia
Introduction
All healthy nontraveling Muslims are required to abstain from taking any food or 
beverages between dawn and sunset (fasting) for one complete lunar month every year 
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(ie, the month of Ramadan).1 Diabetes is one of the key 
diseases that need careful observation during Ramadan.2 
Patients with diabetes may face possible major metabolic 
complications during fasting, including hypoglycemia, 
hyperglycemia with or without the risk of impending ketosis, 
dehydration, and thrombosis.3–5 Saudi Arabia has one of the 
highest diabetes prevalence in the world.6,7 Additionally, more 
than half of the top ten countries with the highest diabetes 
prevalence worldwide have a majority of Muslim population.7 
Since fasting is regarded by Islam as a way of practicing 
patience and good manners rather than creating excessive 
hardship or safety challenge, patients with very high and high 
risk of diabetic complications as described by the American 
Diabetic Association are advised not to fast, whereas patients 
with low and medium risk are expected to fast.8–10
Although religiously exempted, the vast majority of Saudi 
patients with type 2 diabetes (T2D) insist on fasting during 
Ramadan.5,11 As the daily fasting hours varies by season and 
geographic locations, the current Ramadan seasons come 
during summer months with hot weather and long fasting 
duration, reaching ~15 hours in most Islamic countries, 
including Saudi Arabia.12 This probably increases the risk 
of acute diabetic complications. Lack of patient education 
prior to Ramadan may contribute to suboptimal practices.13 
Many of the diabetic patients who fast in this month with-
out any medical guidance often end up developing acute 
complications.14
Current guidelines recommend that diabetic patients 
should have counseling and education about the need to 
modify medication dose and timing, dietary habits, physical 
activity, and self-monitoring of blood sugar to reduce the risk 
of acute diabetic complications.3,9
Two studies from Pakistan and the UK have shown the 
Ramadan education program to be successful in protecting 
against serious acute diabetic complications.15,16 Moreover, 
the current management guidelines stress on individual-
ized approach of diabetic care during Ramadan.3,9 There-
fore, as diabetes management in Ramadan needs special 
considerations, there are several guidelines addressing its 
management in Ramadan, including International Diabetes 
Federation, the Diabetes and Ramadan International Alliance 
practical guidelines,17 and others.9,18
Despite the high prevalence of diabetes and difficult 
environmental conditions,6,7,12 there is a lack of studies that 
have examined the impact of such focused education program 
among Saudi patients with T2D. Therefore, the aim of this 
study is to examine the impact of Ramadan focused educa-
tion program (RFEP) on hypoglycemia, glycemic control, 
and other clinical and metabolic parameters among a group 
of T2D patients receiving care at a primary care center in 
Riyadh, Saudi Arabia.
Methods
setting
The study was conducted in Al-Wazarat Healthcare Center, 
a big family medicine center in Riyadh, Saudi Arabia. The 
total monthly number of diabetic patients visiting the center 
is ~13,000. Diabetic patients are served by family medicine 
clinics (six morning and five afternoon clinics) run by family 
physicians, a clinical pharmacy clinic (covers ten sessions 
per week) run by a clinical pharmacist, and other clinics run 
by diabetic educator, health educator, dietitian, and social 
worker. The current data are collected from the clinical 
pharmacy clinic.
Population
The study included patients with T2D who were receiving 
care at the Al-Wazarat Healthcare Center at the time of the 
study. Exclusion criteria included serious comorbidities such 
as unstable angina or severe hepatic/renal disease, elderly 
patients with alertness problems, newly diagnosed T2D 
(,3 months), recent hospitalization, hypoglycemia during 
the past month or unawareness of hypoglycemia, and partially 
or completely nonfasting during the month of Ramadan.
Design
A nonrandomized interventional controlled design was used 
between June 2013 and February 2014. The study was done 
in three phases: first phase (2–3 weeks before Ramadan, 
enrollment), second phase (the third week of Ramadan), 
and third phase (4 weeks after Ramadan, HbA1c measured 
12 weeks after Ramadan). The study was approved by the 
research committee in Prince Sultan Military Medical City, 
Riyadh, Saudi Arabia.
intervention
The intervention group received the RFEP before and 
after Ramadan while the control group received standard 
diabetic care. The standard care was provided as per the 
American Diabetes Association standard of medical care 
and guidelines.19–21 The RFEP was carried out by the 
clinical pharmacist, primary care physician, and dietician 
through individual and/or group sessions (as appropriate) 
for ~40–60 minutes. The educational intervention included 
audiovisual material and written brochures focused on dia-
betes self-care, including signs and symptoms of hyper- and 
hypoglycemia, self-monitoring of blood glucose, physical 
activity, care of diabetic foot, and management of acute 
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complications. Patients were encouraged to frequently 
monitor for glycemia and immediately end their fast in 
case of hypoglycemia (blood glucose ,60 mg/dL). Patients 
were also advised to adjust the dosage and timing of oral 
hypoglycemic agents and insulin according to the 2010 
recommendations for management of diabetes during 
Ramadan.9 For example, two-third of biguanide or met-
formin or insulin dose should be given at sunset meal, while 
a one-third of the dose should be given before the predawn 
meal. Additionally, patients received individualized diet 
advice (by dietician), including diet adjustment, preferred 
and nonpreferred food items, preferred way for breaking 
fasting, and best timing of second meal. The post-Ramadan 
education was focused on readjusting antidiabetic medica-
tions to prediabetic levels according to blood glucose level 
and clinical parameters.
Outcome
The main study outcome was postintervention change of 
HbA1c and hypoglycemia. Glycemic control was defined 
as HbA1c ,7%. The risk of hypoglycemia was assessed 
using hypoglycemia score. Other outcomes included postint-
ervention change of body weight, blood pressure, and lipid 
profile. The outcomes were measured before, during, and 
after Ramadan.
sampling and recruitment
Patients were recruited from daily follow-up in the clinical 
pharmacy clinic using the convenience sampling technique. 
Patients who meet the eligibility criteria were informed 
about the study during their regular care before Ramadan. 
Patients who were able to provide an informed consent were 
included in the study. The study controls were recruited con-
secutively after completing the recruitment of the patients 
in the intervention.
sample size calculation
A number of studies showed that the patients who received 
Ramadan-focused education had ~60% reduced risk of 
hypoglycemic events compared to the control group.15,16 
Therefore, to be able to detect 60% risk reduction of hypo-
glycemic events, we estimated that a total of 266 participants 
are required, assuming 20% prevalence of hypoglycemic 
events in the control group, 80% power, and 95% two-sided 
confidence level. Additionally, to detect an absolute differ-
ence (increase or reduction) in HbA1c by 1%, we will need 
198 patients (99 in each group) assuming 9% HbA1c in the 
control group, standard deviation of 2.5%, 80% power, and 
95% two-sided confidence level.
Data collection tools
Data were collected through a structured questionnaire, 
which included sociodemographic information, duration of 
diabetes, clinical and metabolic parameters, such as body 
mass index (BMI), systolic and diastolic blood pressure, 
lipid profile, HbA1c, current antidiabetic medications and 
hypoglycemia questionnaire introduced by the Hypoglycemic 
Health Association of Australia.22 Face and content validity 
of the questionnaire was done by three experts in the field 
of diabetes management. Since the questionnaire needed to 
be administered in Arabic, bidirectional translation of the 
questionnaire, including the hypoglycemia part, was done. 
Additionally, pilot study was done on 15 participants and 
the feedback was used to improve the understanding of the 
questionnaire. Reliability of the hypoglycemia questionnaire 
was found to be satisfactory (Cronbach’s alpha of 0.873).
statistical methods
Patients’ demographic, clinical, and biomedical informa-
tion were presented as mean and standard deviation for 
continuous variables, and frequency and percentages for 
categorical variables. To examine the significance of the 
changes in glycemic control and other study outcomes 
across the three phases of the study, repeated measures 
analysis of variance was run for continuous variables. For 
the repeated measures analysis of variance, the P-value of 
Wilks’ Lambda is reported and when statistically significant, 
a post hoc analysis was performed using Bonferroni test to 
adjust for multiple comparisons. For categorical variables, 
Mantel–Haenszel chi-square was used. To examine the 
difference in study outcomes between the intervention and 
control groups during the study phases, independent t-test 
(or its equivalent Mann–Whitney U-test) was used for con-
tinuous variables and chi-square for categorical variables. 
The percentage change of the study outcomes was defined 
as the amount of post-/preintervention change in relation 
to the preintervention level. The difference in the percent-
age change of the study outcomes between the two groups 
were examined using t-test, which was used for continuous 
variables, and chi-square for categorical variables. To detect 
group difference in post-Ramadan reduction in HbA1c and 
hypoglycemia score after adjusting for several demographic 
characteristics, a multivariate linear regression analysis 
was run. All P-values were two-tailed. P-value ,0.05 was 
considered as significant. SPSS software (release 20.0, IBM 
Corporation, Armonk, NY, USA) was used for all statistical 
analyses. Sample size calculation was done using OpenEpi 
software (version 2.2, Copyright© 2003, 2007 Andrew G. 
Dean and Kevin M. Sullivan, Atlanta, GA, USA).
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Results
A total of 262 patients with T2D were included in the study; 
140 patients in the intervention group and 122 patients in 
the control group. The demographic and clinical charac-
teristics of both groups are described in Table 1. The mean 
age was similar in both groups (55.12±12.76 years in the 
intervention group vs 56.06±11.08 years in the control). The 
majority of patients were females in both groups (60.0% 
vs 66.4%, respectively). The intervention group and the 
control group were similar in terms of BMI (32.93±6.70 vs 
32.71±7.14, respectively) similar blood pressure (68.6% vs 
71.3%, respectively, had similar blood pressure). However, 
a higher proportion of patients in the intervention group 
were living outside Riyadh compared with the control 
group (14.3% vs 6.6%, respectively P=0.043). Also, a 
higher proportion of the intervention were unemployed 
compared with the control group (46.4% vs 12.3%, respec-
tively P,0.001).
Table 1 Baseline demographic and clinical characteristics in the intervention and control groups
Variable Intervention (n=140) Control (n=122) Test value P-value
Mean ± SD
N (%)
Mean ± SD 
N (%)
Age (years)
Mean ± sD 55.12±12.76 56.06±11.08 t=0.630 0.530
,50 42 (30.0) 30 (24.6) χ2=4.675 0.097
50–59 52 (37.1) 36 (29.5)
$60 46 (32.9) 56 (45.9)
Sex
Male 56 (40.0) 41 (33.6) χ2=1.143 0.285
Female 84 (60.0) 81 (66.4)
Residence
riyadh 120 (85.7) 114 (93.4) χ2=4.079 0.043*
Outside riyadh 20 (14.3) 8 (6.6)
Job status
Unemployed 65 (46.4) 15 (12.3) χ2=35.809 ,0.001*
Working 75 (53.6) 107 (87.7)
Body weight 84.16±18.04 81.01±17.71 t=1.395 0.164
BMI
Mean ± sD 32.93±6.70 32.71±7.14 t=0.250 0.803
normal (,25) 15 (10.7) 11 (9.0) χ2=1.971 0.578
Overweight (25–29) 32 (22.9) 37 (30.3)
Obese (30–34) 40 (28.6) 31 (25.4)
Morbid obese ($35) 50 (35.7) 40 (32.8)
BP
hypertension (.130/80) 96 (68.6) 87 (71.3) χ2=0.232 0.630
systolic BP 130.14±13.85 130.12±15.40 t=0.011 0.991
Diastolic BP 73.34±8.94 72.98±8.88 t=0.319 0.750
Diabetes and its management
Duration (years) 12.95±8.39 12.86±7.61 U=0.092 0.927
On oral medications 118 (84.3) 101 (82.8) χ2=0.107 0.744
On insulin 134 (95.7) 111 (91.0) χ2=2.404 0.121
number of oral medications 0.97±0.55 0.88±0.47 U=1.479 0.140
number of insulin types 1.71±0.57 1.14±0.55 U=8.307 ,0.001*
hypoglycemia score 14.21±8.50 14.01±5.10 t=0.234 0.815
Acute complications** 0 (0.0) 6 (4.9) χ2=7.047 0.008*
hbA1c 9.79±1.89 10.04±1.47 t=-1.196 0.233
Lipid profile
lDl cholesterol 2.41±0.91 2.53±0.86 t=-1.041 0.299
hDl cholesterol 1.14±0.30 1.14±0.30 t=-0.075 0.940
Total cholesterol 4.35±1.13 4.42±1.27 t=-0.475 0.635
Triglycerides 1.62±0.79 1.86±1.48 t=-1.665 0.097
Notes: χ2, chi-square test; t, student t-test; U, Mann–Whitney U-test. **Complications that occurred in the previous Ramadan. *Statistically significant difference at P,0.05.
Abbreviations: BMi, body mass index; BP, blood pressure; hDl, high-density lipoprotein; lDl, low-density lipoprotein; sD, standard deviation.
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The average duration of diabetes was ~13 years in both 
groups (Table 1). The majority of patients in both groups 
were using insulin (95.7% vs 91.0%, respectively) and oral 
antidiabetic medications (84.3% vs 82.8%, respectively). 
Patients in the intervention group had more mixed types of 
insulin (1.71±0.57 vs 1.14±0.55, P,0.001) but similar num-
ber of oral antidiabetic medications. Patients in both groups 
had similar HbA1c (9.79±1.89 vs 10.04±1.47, respectively) 
and hypoglycemia score (14.21±8.50 vs 14.01±5.10). 
However, patients in the intervention group had no acute 
complications compared with 4.9% in the control group 
(P=0.008). Both groups had similar lipid profile, including 
low-density lipoprotein (LDL), high-density lipoprotein, and 
total cholesterol and triglycerides.
Table 2 summarizes the impact of RFEP on physical, 
physiological, and biomedical parameters by comparing the 
Table 2 impact of ramadan focused education program on clinical characteristics during the study phases in the intervention and 
control groups
Variable Pre-Ramadan During Ramadan Post-Ramadan Phase difference
Mean ± SD Mean ± SD Mean ± SD P-value
Body weight (kg)
intervention 84.16±18.04 85.85±17.37 85.38±17.09 0.063
control 81.01±17.71 81.30±17.48 80.21±17.13 0.434
group difference P=0.164 P=0.038* P=0.017*
BMI
intervention 32.93±6.70 33.74±6.46 33.49±6.52 0.296
control 32.71±7.14 32.45#±7.00 31.50#±6.63 0.013
group difference P=0.803 P=0.126 P=0.016*
Systolic BP
intervention 130.14±13.85 130.87±15.57 130.52±15.71 0.876
control 130.12±15.40 131.20±15.24 130.21±14.25 0.714
group difference P=0.991 P=0.865 P=0.869
Diastolic BP
intervention 73.34±8.94 72.29±10.31 72.39±9.77 0.558
control 72.98±8.88 73.30±9.30 72.98±8.78 0.925
group difference P=0.750 P=0.408 P=0.605
LDL cholesterol
intervention 2.41#±0.91 2.12#,$±0.68 2.28$±0.73 ,0.001*
control 2.53±0.86 2.46±0.89 2.60±0.98 0.109
group difference P=0.299 P=0.001* P=0.003*
HDL cholesterol
intervention 1.14#,$±0.30 1.19#±0.31 1.23$±0.38 0.001*
control 1.14#,$±0.30 1.24#,^±0.33 1.29$,^±0.34 ,0.001*
group difference P=0.940 P=0.211 P=0.214
Total cholesterol
intervention 4.35#,$±1.13 4.00#±0.91 4.08$±1.06 ,0.001*
control 4.42±1.27 4.26±1.18 4.32±1.23 0.319
group difference P=0.635 P=0.047* P=0.088
Triglycerides
intervention 1.62#±0.79 1.49#±0.72 1.53±0.93 0.028*
control 1.86±1.48 1.68±0.87 1.75±0.90 0.260
group difference P=0.097 P=0.054 P=0.053
Number of oral medications
intervention 0.97±0.55 0.99±0.57 0.98±0.57 0.874
control 0.88±0.47 0.84±0.46 0.89±0.53 0.438
group difference P=0.140 P=0.023* P=0.212
Number of insulin types
intervention 1.71±0.57 1.64±0.63 1.64±0.61 0.331
control 1.14±0.55 1.07±0.53 1.11±0.52 0.063
group difference P,0.001* P,0.001* P,0.001*
Note: symbols (#, $, ^) indicate the statistical differences between the phases (*P,0.05).
Abbreviations: BMi, body mass index; BP, blood pressure; hDl, high-density lipoprotein; lDl, low-density lipoprotein; sD, standard deviation.
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three phases of the study. Both LDL and total cholesterol 
significantly decreased in the intervention group during 
Ramadan and became significantly lower than the control 
group. However, such changes were partially lost after 
Ramadan. While both intervention and control groups 
continued to show improvement of high-density lipopro-
tein cholesterol during and after Ramadan, there was no 
statistically significant difference between the intervention 
and the control group. While body weight and BMI did not 
significantly change during the study, the slight baseline dif-
ference between groups (being lower in the control group) 
widen after Ramadan to become significant. On the other 
hand, the number of insulin types remained consistently 
higher in the intervention group compared with control 
group without any significant change during the study. 
Additionally, there were no changes in the blood pressure 
during the study.
Table 3 shows the impact of RFEP on glycemic control 
and hypoglycemia score. HbA1c levels were 9.79, 8.26, 
and 8.52 before, during, and after Ramadan in the interven-
tion group, respectively (P,0.001) and 10.04, 9.54, and 
9.59 in the control group, respectively (P,0.001). Both 
groups were significantly different at the end of the study 
(P,0.001). Those who had targeted glycemic control (,7) 
significantly increased during the study in the intervention 
(P=0.002) but not the control (P=0.711), and the significant 
difference between both groups before Ramadan (8.6% vs 
1.6%, P=0.013) significantly widen after Ramadan (19.3% vs 
3.3%, P,0.001). The mean of hypoglycemia scores before, 
during, and after Ramadan was 14.21, 6.36, and 5.44 in 
the intervention group, respectively, (P,0.001) and 14.01, 
13.46, and 9.27 in the control group, respectively (P,0.001). 
Both groups were significantly different at the end of the 
study (P,0.001).
As shown in Figure 1, the post-Ramadan reduction of 
both HbA1c levels and hypoglycemia score was significantly 
higher in intervention compared with control groups (-13.0% 
vs -4.5%, P=0.004 for HbA1c levels and -61.7% vs -33.8%, 
P,0.001 for hypoglycemia score). Similarly, post-Ramadan 
achievement of the target HbA1c (,7) and hypoglycemia 
score (,8) were more in intervention compared with control 
groups. In Table 4, multivariate linear regression analysis 
adjusted for age, sex, BMI, education, residence, and job 
showed 7.2% more post-Ramadan reduction in HbA1c 
(P=0.004) and 3.16 points more post-Ramadan reduction 
in hypoglycemia score (P,0.001) in the intervention group 
compared with the control group.
Discussion
General education programs that focus on self-management 
of diabetes care have been shown in several studies to have a 
beneficial effect on the glycemic control and other manage-
ment outcomes in patients with T2D, both in the short- and 
probably the long-term as well.23,24 Moreover, education 
Table 3 impact of ramadan focused education program on glycemic control and hypoglycemia score during the study phases in the 
intervention and control groups
Variable Pre-Ramadan During Ramadan Post-Ramadan Phase difference
Mean ± SD
N (%)
Mean ± SD
N (%)
Mean ± SD
N (%)
P-value
HbA1c
intervention 9.79#,$±1.89 8.26#±1.54 8.52$±1.61 ,0.001*
control 10.04#,$±1.47 9.54#±1.38 9.59$±1.79 ,0.001*
group difference (repeated measure) P=0.233 P#0.001* P#0.001*
HbA1c ,7
intervention 12 (8.6) 34 (24.3) 27 (19.3) 0.002*
control 2 (1.6) 3 (2.5) 4 (3.3) 0.711
group difference P=0.013* P#0.001* P#0.001*
Hypoglycemia score
intervention 14.21#,$±8.50 6.36#±6.17 5.44$±5.55 ,0.001*
control 14.01#±5.10 13.46$±5.30 9.27#,$±4.65 ,0.001*
group difference P=0.815 P#0.001* P#0.001*
Hypoglycemia score ,8
intervention 35 (25.0) 95 (67.9) 103 (73.6) ,0.001*
control 10 (8.2) 15 (12.3) 41 (33.6) ,0.001*
group difference P,0.001* P,0.001* P,0.001*
Note: symbols (#, $, ^) indicate the statistical differences between the phases (*P,0.05).
Abbreviation: sD, standard deviation.
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Figure 1 Post-ramadan percent changes (compared with pre-ramadan levels) of glycemic control and hypoglycemia score in the intervention and control groups.
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Table 4 Multiple linear regression model to predict hbA1c and hypoglycemia score by the study groupsa
Variable Unstandardized 
coefficients
Standardized 
coefficients
t-test P-value 95% confidence
interval for B
B Standard error Lower Upper
HbA1c (%)
constant -17.75 3.86 -4.602 ,0.001 -25.35 -10.16
intervention vs control group -7.20 2.49 -0.18 -2.888 0.004 -12.11 -2.29
Hypoglycemia (points)
constant -12.15 1.74 6.977 ,0.001 8.73 -15.57
intervention vs control group -3.16 0.50 -0.22 6.351 ,0.001 2.19 -4.14
Age 0.08 0.02 0.14 -3.700 ,0.001 0.13 0.04
education 0.81 0.20 0.16 -4.114 ,0.001 1.20 0.42
Notes: r-square =0.03. aAdjusted for age, sex, education, residence, job, BMi.
Abbreviation: BMi, body mass index.
of diabetes management is more critical for patients with 
T2D who insist to fast during Ramadan. However, some 
studies from other countries have shown that education 
could increase the awareness of adverse effects and proper 
management of diabetes.25,26 Fasting during Ramadan is a 
great challenge due to sudden alteration in daily dietary 
and physical activity, which may represent a consider-
able risk in some diabetic patients.3–5 For example, studies 
done in multiple countries showed that fasting may be 
responsible for up to sevenfold higher risk of hypoglyce-
mia, especially among those on insulin and those who are 
physically active.11,16
The educational intervention received by the study 
patients was a multifaceted program run by different spe-
cialties, tailored for individual needs, and covering all 
standard recommendations for better diabetic management 
during Ramadan, including frequent glucose monitoring, 
medication and dose adjustments, proper meal planning, 
proper maintaining of physical activity, and situations that 
require breaking the fast.3,9
The current finding showed a beneficial impact of RFEP 
on the risk of hypoglycemia. Almost all the previous studies 
that examined the impact of similar education programs 
showed protective effect on the risk of hypoglycemia.15,16,27 
For example, pre-Ramadan-focused education among UK 
Muslim patients with T2D was associated with approximately 
60% reduction in hypoglycemia during Ramadan compared 
with fourfold increase in hypoglycemia among controls.16 
Similarly, a prospective study in Pakistan showed that the 
majority of outpatients who attended two educational ses-
sions on drug dosage and timing alteration, glucose moni-
toring, and dietary and lifestyle modifications did not have 
any serious acute diabetic complications during Ramadan.15 
Additionally, hypoglycemia was less frequently seen during 
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Ramadan among fasting diabetic patients in UAE who 
received pre-Ramadan targeted education compared with 
their control counterparts (27% vs 6%). The education-
directed modification in lifestyle and medication (type, 
dose, and timing) may have resulted in minimizing the risk 
of acute complications in our patients.25 Although to a much 
lesser extent, reducing the risk of hypoglycemia in the current 
study was also shown among the control group. This could 
be explained by the fact that there is generally good standard 
diabetes management in the clinic.
The current study showed a beneficial impact of RFEP on 
glycemic control and hypoglycemia. However, improvement 
in hypoglycemia was much more than the improvement in 
the glycemic control. This could be explained by the fact 
that considerable changes in HbA1c needs longer duration of 
sustained blood glucose control, which is beyond the 1-month 
Ramadan fasting. Pre-Ramadan education was associated 
with generally modest positive impact on glycemic control 
in the majority of previous studies15,16,27 but not all of them.28 
Interestingly, unlike the risk of hypoglycemia, the impact 
of Ramadan fasting on biochemical parameters is probably 
mild. A couple of reviews showed that the majority of studies 
reported no change in HbA1c in patients with T2D.29,30 On 
the other hand, smaller number of studies showed decrease 
or increase of HbA1c during Ramadan fasting.29,30
The current study showed a mild positive impact of RFEP 
on lipid profile that was rapidly lost after Ramadan. Addi-
tionally, there was no beneficial impact on blood pressure or 
body weight. Similar to our results, pre-Ramadan targeted 
diabetes education in UAE was associated with insignificant 
changes in total cholesterol, triglycerides, and body weight.27 
Additionally, pre-Ramadan-focused education among UK 
Muslim patients with T2D was associated with only 0.7 kg 
weight loss in the intervention and 0.6 kg weight gain in the 
control group after Ramadan.16 Unlike acute complications 
and glycemic control, body weight, blood pressure, and lipid 
profile were rarely used as an outcome for pre-Ramadan 
education programs in previous studies. On the other hand, 
several studies showed that Ramadan fasting has minimal 
impact on lipid profile of diabetic patients, with some 
studies showing decrease, increase, or no change of blood 
cholesterol.12,29,30 Additionally, it was shown that Ramadan 
fasting is associated with no weight change in 50%–60% but 
weight gain in 20%–25% of individuals.31
Strengths and limitations
The current study had strengths; it used a controlled design for 
measuring multiple outcomes including acute complications 
and biomedical parameters, measured during three phases 
(pre-, during, post-Ramadan). Nevertheless, we acknowledge 
some limitations. The nonrandomized approach is a limita-
tion of this study, as the subjects were first enrolled into the 
intervention arm and then the control arm subjects were 
enrolled. However, this approach is not uncommon in the 
literature.32,33 According to Falk and Hagesund, this approach 
is considered appropriate if the purpose of study design was 
to mimic the clinical routine in the primary care setting, and 
to compare the intervention with the ordinary care without 
the opportunity to have this intervention.32
Moreover, regarding the comparability between the two 
arms in terms of the baseline characteristics, there were no 
statistically significant differences between the intervention 
and the control group for most demographic characteristics 
and clinical parameters. However, there were few differences, 
particularly in terms of residency and job status. There was a 
higher proportion of patients in the intervention group who 
were living outside Riyadh compared with the control group. 
Moreover, patients in the intervention group had more mixed 
types of insulin and hence had more tendency to hypoglyce-
mia. However, the program was effective in reducing the risk 
of hypoglycemia despite the challenge that the intervention 
group might be more difficult to manage in this particular 
aspect. However, we believe the impact of these differences is 
minimal, as evidenced by maintaining the group difference in 
the outcome in multivariate analysis. Therefore, overall, we 
believe that study results are robust. However, these limita-
tions should be taken into consideration when interpreting 
the results and conclusions of the study.
Conclusion
Ramadan educational program had a positive impact, with 
reduction of hypoglycemic risk, HbA1c, and LDL choles-
terol. Therefore, it could be recommended for patients with 
increased risk of hypoglycemia during Ramadan fasting.
Disclosure
The authors report no conflicts of interest in this work.
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